US 11236166
CD8 binding agents
granted A61KA61K2039/505A61K2039/57
Quick answer
US patent 11236166 (CD8 binding agents) held by Orionis Biosciences, Inc expires Mon Jan 27 2042 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Orionis Biosciences, Inc
- Grant date
- Tue Feb 01 2022 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Jan 27 2042 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 9
- CPC classes
- A61K, A61K2039/505, A61K2039/57, A61K38/00, A61K39/395